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Abstract
Background: Most studies on barriers and facilitators to implementation of patient decision aids (PDAs) are
conducted in the west; hence, the findings may not be transferable to developing countries. This study aims to use
a locally developed insulin PDA as an exemplar to explore the barriers and facilitators to implementing PDAs in
Malaysia, an upper middle-income country in Asia.
Methods: Qualitative methodology was adopted. Nine in-depth interviews (IDIs) and three focus group discussions
(FGDs) were conducted with policymakers (n = 6), medical officers (n = 13), diabetes educators (n = 5) and a nurse,
who were involved in insulin initiation management at an academic primary care clinic. The interviews were
conducted with the aid of a semi-structured interview guide based on the Theoretical Domains Framework. The
interviews were audio-recorded, transcribed verbatim and analyzed using a thematic approach.
Results: Five themes emerged, and they were lack of shared decision-making (SDM) culture, role boundary, lack of
continuity of care, impact on consultation time and reminder network. Healthcare providers’ (HCPs) paternalistic
attitude, patients’ passivity and patient trust in physicians rendered SDM challenging which affected the
implementation of the PDA. Clear role boundaries between the doctors and nurses made collaborative
implementation of the PDA challenging, as nurses may not view the use of insulin PDA to be part of their job
scope. The lack of continuity of care might cause difficulties for doctors to follow up on insulin PDA use with their
patient. While time was the most commonly cited barrier for PDA implementation, use of the PDA might reduce
consultation time. A reminder network was suggested to address the issue of forgetfulness as well as to trigger
interest in using the PDA. The suggested reminders were peer reminders (i.e. HCPs reminding one another to use
the PDA) and system reminders (e.g. incorporating electronic medical record prompts, displaying posters/notices,
making the insulin PDA available and visible in the consultation rooms).
Conclusions: When implementing PDAs, it is crucial to consider the healthcare culture and system, particularly in
developing countries such as Malaysia where concepts of SDM and PDAs are still novel.
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Background
Shared decision-making (SDM) is part of patient-centred
care whereby patients and clinicians decide on a treat-
ment together. This is particularly relevant when the
decision is preference-sensitive [1]. One way to promote
SDM is to use a patient decision aid (PDA), which pro-
vides information about the decision, available treatment
options, benefits and risks of each option and ways to
clarify patient values [2]. In a Cochrane Review of 115
randomized controlled trials, PDAs have been proven to
be effective in involving patients in SDM and improving
their decision quality [2]. However, the adoption and im-
plementation of PDAs in clinical practice remains poor
[3–5]. One study has found that only about 10% of
eligible primary care patients actually received PDAs
despite clinic-wide PDA adoption [4].
There are many factors that influence the implementa-
tion of SDM and PDAs. Studies have highlighted barriers
such as time constraints, healthcare professionals’ attitude,
perceived legitimacy of the PDA, lack of applicability due
to patient characteristics, clinic capacity, processes of care
and the healthcare environment [6–8]. Among the facilita-
tors were provider’s motivation, provision of training and
skills development for providers, identification of a clinical
champion, introduction of a system to identify eligible
patients to use PDAs ahead of clinical consultations, posi-
tive impact on the clinical process and patient outcomes
[7, 8]. However, the relative influence of these factors
varies across different countries.
As most of the studies on barriers and facilitators to im-
plementation of PDAs are conducted in the west [6–8],
the findings may not be transferable to Asian countries,
most of which are developing countries, and issues such
as socio-cultural barriers (language barrier and physician
paternalism) and lack of resources (infrastructure or tech-
nology development) may be more significant compared
to developed countries. Nevertheless, studies have shown
that patients in Asia want to be involved in SDM [9, 10]
and there are an increasing number of PDAs being devel-
oped in the region [11, 12]. However, no Asian studies
have reported the implementation of these PDAs.
Malaysia is a developing upper middle-income country
in Southeast Asia [13]. It has a population of 28.3 million,
comprising three main ethnic groups namely Malay
(67.4%), Chinese (24.6%) and Indian (7.3%) [14]. The im-
plementation of SDM in Malaysia is hampered by several
factors including the multi-cultural and language diversity
of the population and the lack of patient involvement in
healthcare [15]. In Malaysia, although the national lan-
guage is the Malay language, not all Chinese or Indian
patients are fluent in this language. Furthermore, each
ethnic group has their own cultural norms and beliefs
when it comes to health. Thus, doctors and patients may
be mismatched linguistically as well as culturally. As an
attempt to advance SDM, several Malaysian PDAs have
been developed for patients who are making a decision on
insulin use [12], early breast cancer [16] and early prostate
cancer treatment [17]. These PDAs are available in the
Malay, Chinese, Tamil and English language to facilitate
decision-making as they will be able to read and under-
stand the PDA in their preferred language. Furthermore,
these PDAs explored cultural beliefs of the major eth-
nicities in Malaysia. Nevertheless, formal implementa-
tion of these PDAs has not been conducted. Therefore,
this study aims to use a locally developed insulin PDA
(http://dmit.um.edu.my/?modul=DMIT_PDA) [12, 18]
as an exemplar to explore the barriers and facilitators
to implementing PDAs in a developing country.
Methods
Study design
This study adopted a qualitative methodology to explore
the factors influencing implementation of the insulin PDA.
In-depth interviews (IDIs) and focus group discussions
(FGDs) were conducted.
Study setting and participants
Data collection was carried out at an academic primary
care clinic at the University of Malaya Medical Center,
an urban government teaching hospital. In Malaysia, the
majority of diabetes patients are managed in the public
sector where healthcare services are subsidized by the
government. The primary care clinic is an outpatient
clinic which accepts patients from all over Malaysia, and
therefore, it has a high patient load with patients from
various backgrounds. On average, there are 25 doctors
in the clinic, two diabetes educators (DE) and 26 regis-
tered nurses (RN). Generally, patients in the clinic do
not get to decide which doctor to see; hence, they may
not consult the same doctor during the follow up.
There are three groups of healthcare professionals in-
volved in insulin initiation in the clinic: doctors, DEs
and RNs. In the clinic, only doctors (i.e. family medicine
specialists) and medical officers were allowed to pre-
scribe insulin to patients. There is a diabetes education
centre located in the clinic where three DEs, who are
nurses, provide patient education on diabetes, blood glu-
cose monitoring and insulin initiation and injection
techniques after receiving referrals from doctors. To
qualify as a DE, RNs need to complete an advanced
diploma in diabetes education. In the course, the RNs
are trained on diabetes education, treatment and nursing
of diabetes patients (including on insulin initiation).
However, training on SDM and PDA is not part of the
curriculum as the insulin PDA has not been formally in-
troduced or implemented in the healthcare system in
Malaysia. In contrast to DEs, RNs’ tasks are to assist
doctors in the consultation rooms. Of 26 individuals
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who were approached to participate in the study, one
staff nurse refused due to time constraints.
This study used purposive sampling to recruit partici-
pants who were healthcare policymakers (HPMs) and
healthcare providers (HCPs) working in the medical
centre [19]. The inclusion criteria for HPM were those
who were responsible for or involved in making deci-
sions on whether a particular health intervention should
be implemented in the hospital, while for HCPs were
those who were involved in advising patients about insu-
lin initiation. The HPMs recruited included the director-
level hospital manager, Endocrine and Primary Care
Medicine policymakers and hospital matrons. They set
standards of care and implement programmes to im-
prove diabetes care in the hospital. While they perform
managerial tasks, they are also practicing HCPs. HCPs in-
cluded the doctors, DEs and RNs. In order to achieve
maximum variation, we recruited participants from differ-
ent socio-demographic backgrounds (ethnicity, gender)
and included those with and without experience in using
the PDA. The PDA was previously pilot-tested with a
small group of HCPs in the clinic to test its acceptability,
and a few of them had continued using it after the pilot-
testing phase had ended. HPMs were not involved in the
pilot study.
Study instrument
The interviews were conducted with the aid of a semi-
structured interview guide (Table 1), which was devel-
oped based on the Theoretical Domains Framework
(TDF) [20] and a literature review on barriers and facil-
itators to implementing PDAs [7]. The TDF is an over-
arching framework of 14 theoretical domains synthesized
from behaviour change constructs found in 33 behaviour
change theories (Table 2). The TDF was selected as the
theoretical basis for this study because implementation
success is largely dependent on the behaviour change of
the users involved on whether to adopt or reject the im-
plementation innovation. The TDF is comprehensive as it
not only looks into the impact of rational and cognitive
process of an individual but also looks into emotional factors
[21] as well as external, organizational factors such as work-
ing environment and resources that may influence them on
whether or not to adopt a new behaviour or innovation such
as the practice of SDM and use of PDA. Furthermore, the
TDF has been used in many clinical behaviour change im-
plementation research projects [22], which is why it was felt
to be appropriate for this study to understand the factors in-
fluencing implementation of insulin PDA.
Data collection process
HPMs and HCPs who fulfilled the study inclusion
criteria were invited to participate in the study. Prior to
the interviews, eligible participants who consented to
participate in the study were given information about
the insulin PDA, its objective and content, the concept
of SDM and the various modalities (booklet, tablet, web-
site) available. A video, which demonstrates how the in-
sulin PDA can be used during a consultation, was shown
to the participants to give them an idea on how the insu-
lin PDA can be used in the clinic. The participants were
also encouraged to think about other ways of imple-
menting the insulin PDA in their practice.
The interviews were conducted between December
2015 and March 2016 by the researchers (WTT, YKL,
CJN) who asked the participants ‘open’ and ‘probing’
questions to explore the factors influencing implementa-
tion of the insulin PDA in their practice. All the interviews
Table 1 Summary of the study interview guide
Preamble: We would like to implement the insulin PDA in the clinic.
We would like to hear your honest opinion on what are the barriers
and facilitators to implementing the insulin PDA in your healthcare
organization so that it is effective and sustainable to be used.
Insulin PDA
• What do you think about the insulin PDA? (Probe: feelings: afraid,
hopeful) (emotions) Would you use this PDA? (intention, beliefs
about consequences, optimism)
Individuals
• Do you think that HCPs’ will want to use the insulin PDA? Why?
(intentions)
• Do you think that insulin PDA will affect your/HCP role? How?
(social professional role and identity)
• Do you think that you/HCPs would remember to use the PDA if it is
implemented? Why? Why not? (memory, attention and decision
processess)
• Do you think that you/HCPs will be confident to use the insulin PDA?
Why?
(beliefs about capabilities)
• How doctors and nurses or other HCPs such as dieticians or
pharmacists play a role in implementing the insulin PDA?
(social professional role and identity)
• Do you think that you/HCPs have the knowledge and skills to use the
insulin PDA? What are the knowledge and skills needed? (knowledge
and skills)
• Do you see any benefit or harm in implementing the PDA in the
current healthcare system? (beliefs about consequences)
• Who do you think can influence you/HCPs whether to use or not to
use the insulin PDA? How? (social influences)
• What can you/HCPs do to use the insulin PDA in their consultation?
(behavioural regulation)
• If you will implement the insulin PDA, what are the goals you/patients
want to achieve? (goals)
Inner context – the clinic
• Does your institution have the resources to implement the insulin
PDA? What are the resources available and what are needed?
• How do you think your organization’s working culture (general
beliefs, values, assumptions that people embrace, receptivity of
a new intervention) will affect the implementation of the PDA?
(environmental context and resources)
Outer context – the healthcare system
• Are you confident/positive/optimistic that the current healthcare
system is capable to successfully implement the insulin PDA despite
any difficulty? Yes/No, why? (beliefs about capabilities; optimism)
• What can be done by the higher-level authority to ensure the
success of the implementation of the PDA? (reinforcements)
• In your opinion, how can we make the implementation of the
insulin PDA sustainable?
Tong et al. Implementation Science  (2017) 12:40 Page 3 of 12
were face-to-face and were conducted in the clinic
consultation rooms during rest times in between clin-
ical consultations, or at the office of the participants.
The interviews lasted from 50 to 90 min. This study was
conducted in the university hospital setting, and three of
the researchers (WTT, YKL, CJN) were known to the
participants as they are based at this university. WTT is a
PhD student, YKL is a lecturer, while both CJN and PYL
are clinical lecturers who specialize in family medicine. All
researchers are experienced in conducting qualitative re-
search. As WTT did not know any of the participants
prior to the interviews, WTT conducted most of the inter-
views (8/12) as YKL and CJN refrained from interviewing
participants whom they knew. PYL did not conduct any
interview. The interviews were audio-recorded, and field
notes were written to document the content of and reflec-
tions on the interviews. The data collection ceased when
data saturation was achieved; that is when the barriers or
facilitators that emerged from the data became repetitive
and there were no more new findings.
Data analysis
All the interviews were transcribed verbatim and checked
for accuracy before being imported into Nvivo software
for data analysis. The researchers (WTT, YKL, CJN, PYL)
familiarized themselves with the first three transcripts and
coded the transcripts independently using a thematic
approach. The transcripts were read and coded line by
line. A code is a short text which represents the meaning
of the text segment. Codes that have similar meaning were
grouped together to form a category, and later the cat-
egories were compared and merged into bigger themes
[23]. Researchers met to discuss the categories and themes
which emerged from their individual analysis. Any dis-
crepancies in the categories and themes were resolved
through consensus before finalizing the coding frame-
work, which was used to analyze the remaining transcripts
by one of the researcher (WTT). Any new codes and
categories that emerged were added to the list of themes
and categories upon consultation with the research team.
The written field notes and interview reflections were tri-
angulated with the results to ensure that the findings were
correctly interpreted and no information were missed out
and to supplement the interview findings. By compar-
ing data from multiple sources, we hope to enhance the
credibility of the findings [24].
Ethics approval
This study received ethics approval from the University
of Malaya Medical Centre Medical Ethics Committee
(reference: MECID.NO: 20158-1600).
Results
Socio-demographic and practice profile of participants
Nine IDIs and three FGDs were conducted with 25 indi-
viduals who participated in the study: the hospital pol-
icymakers (n = 6), medical officers (n = 13), DEs (n = 5)
and a RN. Two of the FGDs were conduced with med-
ical officers (n = 7; n = 6). Another FGD with the nursing
policymakers was conducted with smaller number of
Table 2 TDF [20]
Domain Definition (American Psychological
Associations’ Dictionary of Psychology)
1 Knowledge An awareness of the existence
of something
2 Skills An ability or proficiency acquired
through practice
3 Beliefs about capabilities Acceptance of the truth, reality or
validity about an ability, talent or
facility that a person can put to
constructive use
4 Optimism The confidence that things will
happen for the best or that
desired goals will be attained
5 Beliefs about consequences Acceptance of the truth, reality,
or validity about outcomes of
a behaviour in a given situation
6 Reinforcement Increasing the probability of a
response by arranging a dependent
relationship, or contingency, between
the response and a given stimulus
7 Intentions A conscious decision to perform a
behaviour or a resolve to act in a
certain way
8 Goals Mental representations of outcomes or
end states that an individual wants to
achieve
9 Memory, attention and
decision processes
The ability to retain information,
focus selectively on aspects of the
environment and choose between
two or more alternatives
10 Emotion A complex reaction pattern,
involving experiential, behavioural
and physiological elements, by
which the individual attempts
to deal with a personally
significant matter or event
11 Social/professional role
and identity
A coherent set of behaviours and
displayed personal qualities of an
individual in a social or work setting
12 Environmental context
and resources
Any circumstance of a person’s
situation or environment that
discourages or encourages the
development of skills and abilities,
independence, social competence,
and adaptive behaviour
13 Social influences Those interpersonal processes
that can cause individuals to
change their thoughts, feelings,
or behaviours
14 Behavioural regulation Anything aimed at managing
or changing objectively observed
or measured actions
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participants (n = 3) as they were the only three senior
nursing staff at management level who were felt to be
able to provide feedback on the implementation of the
insulin PDA. There were six participants who have had
experiences in using the insulin PDA (Table 3).
Emerging themes
Five themes emerged from the interviews, and they were
lack of SDM culture, role boundary, lack of continuity of
care (COC), impact on consultation time and reminder
network.
Theme 1: Lack of SDM culture
The participants highlighted that there is a lack
of SDM culture in the current practice as HCPs’
paternalistic attitudes still prevailed whereby doctors
would make treatment decision for patients and did
not like patients to ask too many questions. In addition,
patients tended to play a passive role in decision-
making and trusted the physicians to make the
decision for them. This rendered the lack of need for
SDM and use of the insulin PDA.
I think in our Asian context, we still have this idea of
doctor telling you what to do. I think this shared
decision approach is a concept that developed countries
have but I don’t know whether our culture has reached
this stage or not.//Our practitioners don’t give patients
chance to decide on their own. We like to tell the
patient what to do. So they don’t see the need for this
book. The patients still have the mindset of ‘You tell
me what to do. It’s not my decision, it is your decision, I
just follow you’.//I don’t know whether our patient is
up to that yet for the shared decision part. – IDI 1_DE
1_have not used insulin PDA
Because we are busy in the clinic, sometimes we don’t
like people to ask us a lot of questions. FGD
3_Hospital matron 1_have not used insulin PDA
Table 3 Characteristics of participants
Interview Role Ethnicity Age Sex Experience with
insulin PDA
IDI 1_ Diabetes educator 1 Healthcare provider Chinese 56 Female No
IDI 2_ Diabetes educator 2 Healthcare provider Malay 57 Female Yes
IDI 3_ Diabetes educator 3 Healthcare provider Malay 53 Female No
IDI 4_ Diabetes educator 4 Healthcare provider Malay 35 Female No
IDI 5_ Diabetes educator 5 Healthcare provider Malay 57 Female No
IDI 6_ Registered nurse Healthcare provider Indian 55 Female No
IDI 7_ Primary care policymaker Healthcare policymaker Malay 48 Female No
IDI 8_ Endocrine policymaker Healthcare policymaker Chinese 37 Male No
IDI 11_ Director-level hospital manager Healthcare policymaker Malay 43 Male No
FGD 1_ Medical officer 1 Healthcare provider Malay 35 Female No
FGD 1_ Medical officer 2 Healthcare provider Chinese 32 Female No
FGD 1_ Medical officer 3 Healthcare provider Indian 37 Female Yes
FGD 1_ Medical officer 4 Healthcare provider Indian 35 Male No
FGD 1_ Medical officer 5 Healthcare provider Malay 32 Male No
FGD 1_ Medical officer 6 Healthcare provider Malay 32 Male No
FGD 1_ Medical officer 7 Healthcare provider Indian 39 Male Yes
FGD 2_ Medical officer 8 Healthcare provider Malay 31 Female Yes
FGD 2_ Medical officer 9 Healthcare provider Malay 33 Female No
FGD 2_ Medical officer 10 Healthcare provider Chinese 33 Female Yes
FGD 2_ Medical officer 11 Healthcare provider Chinese 35 Female No
FGD 2_ Medical officer 12 Healthcare provider Malay 36 Female No
FGD 2_ Medical officer 13 Healthcare provider Malay 36 Female Yes
FGD 3_ Hospital matron 1 Healthcare policymaker Malay 56 Female No
FGD 3_ Hospital matron 2 Healthcare policymaker Malay 56 Female No
FGD 3_ Hospital matron 3 Healthcare policymaker Chinese 57 Female No
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Theme 2: Role boundary
There was a clear role boundary between the
doctors and the nurses which made collaborative
implementation of the PDAs challenging. All
participants, including medical officers, felt that the
doctor should be the key person to introduce and
use the insulin PDA with patients because the
decision to initiate insulin treatment lies within the
doctor after reviewing patient’s glycaemic control
and health profile. Furthermore, only doctors have
the authority to prescribe insulin for patients.
I think the initiation [to use insulin PDA] has to
come from the doctor because we are the ones
who will know whether it is appropriate or not to
talk about insulin initiation. I think only doctors
would understand circumstances such as if a
patient has cataract and will not be able to inject
herself or have no social support. Rather than at
the pharmacy end ‘Oh, your Hba1c is very bad.
You should be on insulin, here, take this book’ I
think that is not right. FGD 2_Medical officer
8_have used insulin PDA
But we don’t have so much opportunity to initiate
(insulin PDA use) because instructions are passed down
from the top, ‘ok you do this’. They (doctors) are the
first liner. IDI 1_DE 1_have not used insulin PDA
However, assigning RNs to use the PDA with patients
would not be accepted if it fell outside the scope of RNs’
current duties. For example, when asked if RNs had a role
in using the insulin PDA with patients, participants voiced
that RNs would not perceive the use of insulin PDA to be
part of their job scope. RNs confined their duties only to
pre-determined tasks and would not be interested to per-
form additional tasks. They perceived using the insulin
PDA as an added workload.
But I think because they [RNs] don’t see it as their
role to advise patients about their disease. It is more
of getting the patient in, sorted out, weight, height.
So, I think to get them to start [using insulin PDA] it
might be a bit harder than to get the medical officers
to use it. – IDI 7_Primary care policymaker_have not
used insulin PDA
Nurses, we only want to do what is nursing. We
don’t want to do beyond that. ‘I’m a nurse … why
should I do this, this is nothing concerning me,
this is doctors’ job, not my job’.//‘Oh another
booklet. Another thing to talk to the patient now’.
Anything else is added work. – IDI 6_RN_have not
used insulin PDA
As for DEs, some felt that their role in the PDA
implementation was just ‘taking orders from doctors’ on
when to use the PDA with patients, while some felt that
they could inform patients on when to initiate insulin.
Doctor will say to the patient they have no time [to
use PDA] ‘You go and see the DE’. The decision is
made by doctor. I just follow order. IDI 2_DE 2_have
used insulin PDA
Actually we also have a clinic of our own and patients
come to us we will monitor them. So when we see that
they are losing control then we can tell them that ‘I
think you need insulin already’. So we also have a little
part to play. IDI 1_DE 1_have not used insulin PDA
Theme 3: Lack of COC
Some medical officers have continued the insulin
PDA use after the pilot study because they felt
that the PDA helped to reduce consultation time
and address language barrier when they provided
information to patients who spoke a different
language. However, the use of PDA was later
discontinued due to lack of COC. Furthermore,
as there was no proper record that the insulin
PDA had been given to patients, the medical officer
might not be aware that the patient had already been
introduced to the insulin PDA by another doctor. This
sentiment is shared by both medical officers who
have and have not used the PDA.
Basically, COC is not there. Because doctors don’t get
to see the same patients. We might give this PDA to a
patient this visit. And next visit, you may not be the
one who sees the patient. – FDG 1_Medical officer
4_have not used insulin PDA
The book was in the diabetic education room. So I
did refer patient there so that the nurse can explain
but I’m not sure what the nurse explained to the
patient. FGD 2_Medical officer 13_have used PDA
Furthermore, as the setting was a teaching hospital,
trainee doctors leave after their training is completed.
Therefore, this posed another issue for implementation
as doctors who were trained on how to use the insulin
PDA may leave and new doctors may not be familiar
with the PDA.
We have to train them (on PDA use), so we have to
give them the exposure of what it is like, what
patients are like, but you know it takes several
consultations to fully get that. They can deploy the
book, but then they may not be around next month to
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even follow up. – IDI 8_Endocrine policymaker_have
not used insulin PDA
Theme 4: Impact on consultation time
Time constraints were the most commonly raised
implementation barrier of the PDA among the
participants. Due to high patient load, there were
concerns about taking up extra time to go through
the insulin PDA with patients during consultations.
Time is a problem because there are many patients.
Whether we have enough time to go through (the
insulin PDA) with the patient. – FGD 1_Medical
officer 4_have not used insulin PDA
In contrast, some participants felt that the insulin PDA
might help to reduce consultation time. However, this
is only if patients used the insulin PDA prior to the
clinical consultation such as while waiting for the
doctor or at home. It was felt that patients who have
read the PDA were better prepared to discuss their
concerns with doctors during clinical consultation and
this might help to save time.
This saved time for the doctor. ‘Mr, you read
first, what you don’t understand please come
back to me’. So he would have read the whole
thing. What they didn’t understand they highlight to
you and you address. So your time management
is shortened. – IDI 6_RN_ have not used insulin
PDA
Theme 5: Reminder network
The PDA was not integrated into the care pathway,
and hence, the HCPs might forget to use it with
patients. The participants wanted reminders and
suggested different approaches including peer
reminder, incorporating the PDA into the clinic
electronic medical record (EMR), and displaying
posters or PDAs in the clinic to remind both
HCPs and patients to use the PDA.
Doctors, among doctors [to remind one another].
Sometimes the attendants are also assisting the doctors.
They may not know how to use it, but they will know
there is such a tool.//Nurses who are working in the
clinic with the doctors, they can remind the doctor ‘Hey
doctor you can use the book you know’. – IDI 1_DE
1_have not used insulin PDA
It was proposed that the EMR could be
programmed to identify patients suitable for
using the PDA and to notify the doctors during
the consultation. In addition, the electronic copy
of the PDA should be made available in the
computer’s desktop which can serve as a reminder
for the doctor to use the insulin PDA.
So I suppose what you can do is… if their HbA1c is
above certain level, then have the EMR goes alert,
‘PDA, PDA!’. So either I can give the book or I can
alert them to go to the website. – IDI 7_Primary care
policymaker_have not used insulin PDA
Every day when we see patients, we have to use the
computer. So maybe it should be in the desktop in
PDF so that when we see patients, we just open up
the PDF. FD4 1_Medical officer 4_have not used
insulin PDA
Another type of reminder is to put up posters or
notices about the insulin PDA, as well as making the
insulin PDAs available and visible in the consultation
room. This will help HCPs remember to use the insulin
PDA as well as creating awareness about the insulin
PDA among patients.
Like putting posters in the clinic so that patients or
their carers can see. Then patient can remind doctors
about the book. – FGD 2_Medical officer 13_have
used insulin PDA
But I think if we alert them more they will use it. So
you sort of like, make it available. So I suppose if it is
available in the room, and they are reminded all the
time. I think it is keep being reminded that there is
such a thing. – IDI 7_Primary care policymaker_have
not used insulin PDA
Discussion
This study provides insights into factors influencing
implementation of PDAs from a developing country, a
setting which is scarcely reported. The factors revealed
in our study are not too different from those commonly
reported in the western countries such as lack of SDM
culture [25–27], time constraints [6, 25] and reminders.
Less commonly reported factors which emerged from
our study were role boundary and COC. This study
highlighted a few important domains from the TDF that
could influence SDM implementation in developing
countries. For example, under the ‘environmental con-
text and resources domain’, we found that there was low
awareness and receptivity to SDM among the HCPs,
which then hindered the implementation of PDA in the
Malaysian primary care setting.
The participants of this study were doubtful if the
concept of SDM is culturally acceptable in Malaysia
due to HCP paternalism and patient’s submissiveness
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towards doctors. This resistance to SDM would hinder
the adoption of SDM and subsequently lead to non-use
of the insulin PDA. There is a distinct contrast in SDM
implementation between developed countries (such as
the USA, UK, Germany, Netherlands, Australia, Italy
and Spain) where SDM and the use of PDAs have
already been implemented at policy and legislation levels
[28–31] and developing countries in Asia see slower
progress in adopting SDM and PDAs [15, 32]. In
Switzerland, however, hierarchical structures and asym-
metric physician-patient relationship were reported to
be barriers for SDM implementation despite doctors
recognizing its importance [31]. This shows similarity to
the hierarchical social pattern in Asian culture whereby
doctors are placed at a higher societal stratum [33], and
patients may therefore tend to consign their healthcare
decisions to HCPs. Furthermore, doctors may not wish
to offer a choice to patients as it is considered a good
practice to initiate insulin in patients with T2DM who
are unable to achieve glycaemic control despite taking
maximal oral medications. Patients in the public health
facilities may feel that they may not have control over
their health decision as they only pay a nominal fee (i.e.
‘I get what I pay for’). In addition, they do not have
much freedom to choose the HCP they want to see.
However, Asian studies have shown that many patients
preferred an autonomous (active and shared) role in
decision-making [9, 10]. Thus, to facilitate the use of
PDAs, the concept of SDM needs to be promoted
among HCPs and patients in developing countries.
Zhang et al. [34] highlighted that one way to increase
patient involvement in making treatment decisions is to
increase healthcare professionals’ knowledge about this
concept. HCPs also need to be trained on respecting pa-
tients’ autonomy and how to engage patients in making
decisions about their health care. The Patient Decision
Aids Research Group has created continuous education
such as online tutorials, interactive workshops, perform-
ance feedback and structured protocols in providing de-
cision support [18]. Efforts are also needed to empower
patient in being more involved in their healthcare, and
one way to do that is to conduct public health cam-
paigns [15]. In developed countries such as Australia
and the UK, the ‘AskShareKnow’ [35, 36] and the ‘Ask
three questions’ [37, 38] campaigns are conducted to en-
courage patients to ask their HCPs the three questions
(‘What are my options?’, ‘What are the benefits and
harms?’ and ‘How likely are these going to happen?’) to
increase patient involvement in healthcare. While it has
been shown to improve patient-doctor communication
in SDM in Australia [35], it is unsure if such campaign
would be effective on countries with strong hierarchical
social pattern like in developing countries such as
Malaysia. Among other strategies that have been proposed
to promote SDM in clinical practice, however, at the
macro level in Malaysia are the following: (1) incorpor-
ation of SDM in clinical practice guidelines, (2) advocating
the use of patient decision aids or other decision support
tools in patient care, (3) inclusion of patient involvement
in decision-making as a quality indicator and (4) payment/
reimbursement for practices which implement SDM or
use decision aids [15].
Another factor influencing implementation that was
raised was role boundary of HCPs in the clinic setting.
Role boundary may act both as a facilitator or barrier for
the implementation of the insulin PDA. Being clear of
one’s job responsibilities helped participants decide if
they were the right person to use the insulin PDA. For
example, all participants felt that doctors should intro-
duce and use the insulin PDA, given their authority to
prescribe insulin and familiarity with the patient’s health
profile. Relying solely on doctors would hinder an inter-
professional team approach to using the PDA. Involve-
ment of other HCPs besides physicians may help to
disperse the work needed in providing decision support.
For example, compared to primary care doctors who has
to see high number of patients with various conditions,
DEs would have more time to provide patient counsel-
ling as they only see diabetes patients. Many western
studies have also shown HCPs other than doctors, such
as nurses, social workers, psychologists and allied health
professionals, who play a significant role in ensuring
PDAs are implemented successfully by identifying eli-
gible patients, contacting patients about the PDA and
providing decision coaching [39–41]. Participants of this
current study also suggested that nurses could remind
doctors to use the PDA. To increase DEs’ and nurses’
involvement in insulin PDA implementation, they can be
trained in decision coaching skills, which have been
found to be effective in guiding patients to make an in-
formed decision [42]. SDM and decision coaching training
can be included in the advanced diploma in diabetes edu-
cation and even basic nursing programmes. In addition,
doctors also need to be trained to work with the nurses as
a team to implement PDA in the clinic. A recent study
showed that very few SDM training programmes adopt an
interprofessional approach [43], which could help to
utilize the strengths of each team members to create a
more coordinated and efficient PDA implementation
process.
Time constraints are a universal barrier in implement-
ing SDM as well as PDAs [6, 44]. Two studies reported
longer consultation time with PDA use compared to
usual care [45, 46]. However, some studies indicate
otherwise and one strategy that can be used to address
the time issue is to highlight to HCPs that the use of
PDAs does not always require more time compared to
usual care [2, 47, 48] and that informed decision may be
Tong et al. Implementation Science  (2017) 12:40 Page 8 of 12
achieved more quickly over time [49]. While the first
consultation using the PDA may take a longer time, in-
sulin decision-making over subsequent consultations
may be shorter, and this reduces delay in decision-
making. The participants of this study also felt that pre-
visit usage of the insulin PDA might help to save time.
Brackett et al. [50] have tested a pre-visit model and
found that in addition to time saving, physicians also re-
ported that discussions during a consultation were more
focused and helped to address patient values and prefer-
ences, which may otherwise be overlooked. It also facili-
tated decision-making as patients arrived at the clinic
appointment more prepared to discuss and make a
decision [50]. One strategy used to allay fears over in-
creased time was by asking a mentor or peer expert
to demonstrate how the insulin PDA can be incorpo-
rated into a standard clinical consultation [51, 52]
without taking more time and to emphasize that the
delivery of PDA only becomes easier and possibly faster
with training and practice.
Another important aspect of the implementation of
the insulin PDA is the need to follow up patients (ideally
by the same HCP) to ensure that there is continuity in
the delivery of the insulin PDA. The use of PDAs is not
a one-off event as SDM is a continuous interactive
process between HCPs and patients; hence, COC is cru-
cial in ensuring effective delivery of the insulin PDA.
The lack of COC in the use of PDAs may cause difficul-
ties for patients to raise or discuss issues pertaining to
the PDAs that were brought up in the previous consult-
ation [27]; it also prevents rapport-building between
HCPs and patients that could facilitate informed
decision-making. In Asia, COC is a challenge in health-
care delivery due to high patient load, lack of manpower,
time constraints [53, 54], lack of family physicians and
uncoordinated referral mechanisms [55]. COC is also
difficult particularly in an academic healthcare setting,
where there is a high turnover of staff after the medical
trainees have completed their training [53, 56, 57]. To
address this barrier, systematic documentation of the use
of PDA and its discussions with patients can help to
facilitate communication between different doctors who
follow up the same patients. Furthermore, new HCPs
need to be educated on decision support and PDA use.
Such training can be introduced during the orientation
programme for new HCPs, having a resource person
that provide more information about the PDA in the im-
plementation setting as well as having on-going training
and support to familiarize HCPs with the concept of
SDM and the use of PDAs.
‘Forgetting to use’ has been reported as a barrier in
the implementation of PDAs [58, 59] even after
provision of training and continuing medical education
credits to encourage use among HCPs [58]. Participants
of our study highlighted a reminder network to address
the issue of forgetfulness as well as to trigger interest in
using the insulin PDA. The use of EMR and IT system
has been raised as an effective reminder platform in the
implementation of SDM and PDA; for example, they can
be used to identify eligible patients for PDAs [44] before
their clinic visit, to prescribe PDAs as well as to cue for
PDA use [60]. While HCPs have reported they would be
more likely to use the PDAs if they were reminded
through EMR [4], some felt that an electronic, inter-
active decision aid linked to a computerized reminder
system may not necessarily be better compared to trad-
itional paper resources because of technical issues. The
integration of PDA reminders into the EMR will require
technology support, which can be a significant barrier in
developing countries that are still using paper-based sys-
tems [61]. If technology cannot be adopted to facilitate
implementation, peer support would be another useful
form of reminder, which was also raised by participants
in our study. For peer support to be effective, the work-
ing culture needs to be one that holds the belief that the
use of PDA is the preferred practice style. Efforts are
needed to create awareness on the benefits of PDAs so
that HCPs will be willing to use them. Physician cham-
pion plays an important role in creating awareness about
the availability and the importance of PDAs, and encour-
age the staff to use them; this has been reported as one
of the key factors in the successful implementation of
PDAs [62]. Another reminder that was raised was having
posters and notices to promote the insulin PDA. Pro-
motional brochures placed at exam rooms have been
implemented to increase patients’ interest in decision
aids [4, 26]. However, while it prompted discussions
about PDAs, it did not significantly lead to physicians
prescribing PDA to patients [26]. More studies are
needed to look at the effectiveness of having promo-
tional materials such as posters or notices on HCPs
in remembering to use as well as on patients to initiate
discussions with HCPs on PDAs. Ultimately, HCPs and
patients need to be made aware that long-term patient
engagement in self-management for chronic conditions
like diabetes is crucial in improving diabetes control and
outcome. This would then obviate the need for reminders.
The use of PDA should be integrated as part of the
training on longitudinality of care whereby HCPs and
patients should be made aware that insulin is an option
as diabetes progresses and that PDAs are available to
help them make this decision.
Strengths and limitations of study
This study highlights implementation issues that are per-
tinent to developing countries where literature on barriers
and facilitators to implementation of PDA is scanty. This
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study explored views from a diverse group of key stake-
holders from policymaker, physician, nurse and DE, and
this helps to elicit factors influencing implementation
from various professional levels.
There are a few limitations in this study. First, there
were participants who had not been exposed to or had
no experience in using the insulin PDA; they may not be
able to grasp the concept of the insulin PDA, which in-
volves the process of shared decision-making between
HCP and patients. Instead, they may have thought that
the insulin PDA is just another educational material.
There is a possibility that some issues pertaining to the
implementation processes for PDA may have been omit-
ted. The researchers tried to reduce this limitation by
explaining to the participants the purpose of the insulin
PDA, concept of SDM, its content, as well as showing a
video of a mock consultation using the PDA before con-
ducting the interviews. Second, the data collection was
only conducted in an academic primary care clinic and
did not include other healthcare settings such as public
community health clinics or private practices. Hence,
the findings of this study may not be transferable to
other settings. Third, it is noteworthy that there was a
preponderance of female participants in this study, as
more female than male candidates are interested to pur-
sue family medicine as a specialty in Malaysia. However,
the researchers felt that the participants’ sex may not
have significant impact on the study findings given that
the topic of this study is one that is not gender-sensitive.
Fourth, only HPMs’ and HCPs’ views were gathered in
this study. Patient’s perspectives should also be taken
into account, which are currently being explored in the
next phase of this study. Lastly, there is a possibility that
participants may have provided positive responses or so-
cially desirable answers, as they did not want to criticize
their own practice; researchers tried to offset this bias by
reassuring the participants that confidentiality would be
kept and that their participation in this study would not
affect their work or career.
Conclusions
When implementing PDAs, it is crucial to consider the
healthcare culture and system, particularly in developing
countries such as Malaysia. This study highlights that to
facilitate the implementation and effective use of PDA,
there is a need to change physician’s paternalistic attitude
as well as to promote patient empowerment so that the
concept of SDM can be embraced. The use of an interpro-
fessional approach and reminders should also be consid-
ered when designing strategies for PDAs implementation.
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